Angela Rigopoulos
Target (United States)(US)La Trobe University(AU)Olivia Newton-John Cancer Wellness & Research Centre(AU)Vital Therapies (United States)(US)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Crystallization and Solubility Studies, Medical Imaging Techniques and Applications
Most-Cited Works
- → 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease(2011)331 cited
- → A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake(2005)124 cited
- → The Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor AG1478 Increases the Formation of Inactive Untethered EGFR Dimers(2006)107 cited
- → Enhanced Efficacy of Radioimmunotherapy with 90Y-CHX-A″-DTPA-hu3S193 by Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling with EGFR Tyrosine Kinase Inhibitor AG1478(2005)83 cited
- Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.(2001)
- → Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity(2019)59 cited